PB 84 of 2026
National Health (August 2026 First New Brand Statutory Price Reduction) (Exercise of Ministerial discretion) Determination 2026
I, Soumya Sudarshan, Acting Assistant Secretary, PBS Listing, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make the following determination.
Dated 29 June 2026
SOUMYA SUDARSHAN
Acting Assistant Secretary
PBS Listing, Pricing and Policy Branch
Technology Assessment and Access Division
Department of Health, Disability and Ageing
1 Name
(1) This instrument is the National Health (August 2026 First New Brand Statutory Price Reduction) (Exercise of Ministerial discretion) Determination 2026.
(2) This instrument may also be cited as PB 84 of 2026.
2 Commencement
This instrument commences on 1 August 2026.
3 Authority
This instrument is made under sections 99ACB of the National Health Act 1953.
4 Definitions
Note: A number of expressions used in this instrument are defined in Part VII the Act.
In this instrument:
Act means the National Health Act 1953.
Reduction day refers to 1 August 2026.
5 Brands of pharmaceutical item (not combination items) not subject to a price reduction
- I determine under paragraph 99ACB(6A)(a) of the Act that the agreed price of the brand of pharmaceutical item specified in the table in Part 1 of Schedule 1 that comes into force on the reduction day is to be equal to the approved ex‑manufacturer price, on the day before the determination day, of the listed brands of the existing item.
Schedule 1 Brands of pharmaceutical item (not combination items) not subject to a price reduction
Part 1
Column 1 | Column 2 | |||
Item | Brand of pharmaceutical item | |||
| Drug | Form | Manner of administration | Brand |
1 | Progesterone | Capsule 100 mg | Oral | Progesterone-APX |